Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 443, 897 (26 October 2006) | doi:10.1038/443897a; Published online 25 October 2006
Capital gains
Top of page
Abstract
London is seeking to compete with the Nasdaq as the preferred global venue for science-based companies trying to raise cash. Andrea Chipman reports.
When James Karis needed to raise funds last summer for his company Entelos, based in Foster City, California, he ended up looking far afield. Entelos, which builds computer models of disease for clients in the drug industry, raised the money through an initial public offering on London's Alternative Investment Market (AIM).
To read this story in full you will need to login or make a payment (see right).